Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
- Sprache
-
Englisch
- Identifier
-
1188889710
- Beteiligte Personen und Organisationen
-
Hammerich, Linda
Tacke, Frank
- DOI
-
10.18154/RWTH-2016-03227
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hammerich, Linda
- Tacke, Frank
Ähnliche Objekte (12)
Mechanisms of liver fibrosis resolution
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Molecular interactions between hepatitis B virus and delta virus
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
MCP-1 dependent balance of inflammatory pathways and interplay of immune cells in the liver during injury, fibrosis and injury regression : unterschiedliche MCP-1-abhängige Entzündungsmechanismen und Interaktionen von Immunzellen in der Leber
Mechanisms of liver fibrosis resolution
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Molecular interactions between hepatitis B virus and delta virus
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
MCP-1 dependent balance of inflammatory pathways and interplay of immune cells in the liver during injury, fibrosis and injury regression : unterschiedliche MCP-1-abhängige Entzündungsmechanismen und Interaktionen von Immunzellen in der Leber
Mechanisms of liver fibrosis resolution
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
The Janus-like Face of IL-4R? in Macrophages during Liver Fibrosis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Molecular interactions between hepatitis B virus and delta virus
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
An Unexpected Line of Defense : Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury
Liver Injury and the Macrophage Issue : Molecular and Mechanistic Facts and Their Clinical Relevance
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts